AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Imami, N Hardy, G Gotch, F
Citation: N. Imami et al., Development of immunotherapeutic strategies for HIV-1, EXPERT OP B, 1(5), 2001, pp. 803-816

Authors: Tchilian, EZ Wallace, DL Dawes, R Imami, N Burton, C Gotch, F Beverly, PCL
Citation: Ez. Tchilian et al., A point mutation in CD45 may be associated with an increased risk of HIV-1infection (vol 15, pg 1892, 2001), AIDS, 15(16), 2001, pp. 2210-2210

Authors: Tchilian, EZ Wallace, DL Dawes, R Imami, N Burton, C Gotch, F Beverley, PCL
Citation: Ez. Tchilian et al., A point mutation in CD45 may be associated with an increased risk of HIV-1infection, AIDS, 15(14), 2001, pp. 1892-1894

Authors: Imami, N Hardy, G Burton, C Pires, A Pido-Lopez, J Moss, R Gazzard, B Gotch, F
Citation: N. Imami et al., Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination, IMMUNOL LET, 79(1-2), 2001, pp. 63-76

Authors: Gotch, FM Imami, N
Citation: Fm. Gotch et N. Imami, Outcomes of a trial of HIV-1 immunogen in patients with HIV infection, J AM MED A, 285(17), 2001, pp. 2191-2192

Authors: Tchilian, EZ Wallace, DL Imami, N Liao, HX Burton, C Gotch, F Martinson, J Haynes, BF Beverley, PCL
Citation: Ez. Tchilian et al., The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans, J IMMUNOL, 166(10), 2001, pp. 6144-6148

Authors: Pido-Lopez, J Imami, N Aspinall, R
Citation: J. Pido-lopez et al., Both age and gender affect thymic output: more recent thymic migrants in females than males as they age, CLIN EXP IM, 125(3), 2001, pp. 409-413

Authors: Gotch, F Rutebemberwa, A Jones, G Imami, N Gilmour, J Kaleebu, P Whitworth, J
Citation: F. Gotch et al., Vaccines for the control of HIV/AIDS, TR MED I H, 5(7), 2000, pp. A16-A21

Authors: Imami, N Aspinall, R Gotch, F
Citation: N. Imami et al., Role of the thymus in T lymphocyte reconstitution, TRANSPLANT, 69(11), 2000, pp. 2238-2239

Authors: Wilson, JDK Imami, N Watkins, A Gill, J Hay, P Gazzard, B Westby, M Gotch, FM
Citation: Jdk. Wilson et al., Loss of CD4(+) T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease, J INFEC DIS, 182(3), 2000, pp. 792-798

Authors: Imami, N Antonopoulos, C Hardy, GAD Gazzard, B Gotch, FM
Citation: N. Imami et al., Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy, AIDS RES H, 15(17), 1999, pp. 1499-1508

Authors: Imami, N Hardy, GAD Nelson, MR Morris-Jones, S Al-Shahi, R Antonopoulos, C Gazzard, B Gotch, FM
Citation: N. Imami et al., Induction of HTV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy, CLIN EXP IM, 118(1), 1999, pp. 78-86

Authors: McKay, PF Imami, N Johns, M Taylor-Fishwick, DA Sedibane, LM Totty, NF Hsuan, JJ Palmer, DB George, AJT Foxwell, BMJ Ritter, MA
Citation: Pf. Mckay et al., The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family, EUR J IMMUN, 28(12), 1998, pp. 4071-4083
Risultati: 1-13 |